No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MCK240726P592500
- 10.40
- -3.67-26.08%
15min DelayTrading Jul 22 10:14 ET
10.40High10.40Low
10.40Open14.07Pre Close2 Volume20 Open Interest592.50Strike Price2.08KTurnover12.91%IV0.16%PremiumJul 26, 2024Expiry Date9.47Intrinsic Value100Multiplier4DDays to Expiry0.93Extrinsic Value100Contract SizeAmericanOptions Type-0.8882Delta0.0286Gamma59.19Leverage Ratio-0.1242Theta-0.0343Rho-52.57Eff Leverage0.1172Vega
Intraday
- 5D
- Daily
News
McKesson's Q2 2024 Earnings: What to Expect
Express News | Mckesson Corp : UBS Raises Target Price to $670 From $630
What's in Store for West Pharmaceutical (WST) in Q2 Earnings?
Barclays Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $596
Barclays analyst Stephanie Davis maintains $McKesson(MCK.US)$ with a buy rating, and maintains the target price at $596.According to TipRanks data, the analyst has a success rate of 42.1% and a
McKesson (MCK) Receives a Buy From Barclays
Investors Appear Satisfied With McKesson Corporation's (NYSE:MCK) Prospects
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may consider McKesson Corporation (NYSE:MCK) as a stock to potentially avoid with its 25
Comments
$McKesson(MCK.US$ Hmmm this company has got more liability than assets now. is it still worth so much market cap.
1
McKesson's statutory earnings may not reflect its true productivity due to a large unusual item. Its real earnings power could be less than its statutory profit. Investors should understand the risks, including the identified warning sign with McKesson, before investing.
1
Despite McKesson's EPS growth, market sentiment appears pessimistic. Improved shareholder return suggests business improvement, yet McKesson may not be the best stock to buy, with one warning sign to note.
1
Despite its weaker earnings outlook and slower expected growth, McKesson is trading at a similar P/E to the market, possibly setting investors up for future disappointment if the P/E aligns more with the growth outlook.
3
1
Read more
JamieOliver : Large shogata